Cargando…

Longitudinal Renal Function in Liver Transplant Recipients With Acute-on-Chronic Liver Failure

To analyze the impact of acute-on-chronic liver failure (ACLF) immediately before liver transplantation (LT) on short-term kidney function. METHODS: In this retrospective study, we included 416 of 687 consecutive patients who had an estimated glomerular filtration rates (eGFRs) at 3-month post-LT. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazawa, Masahiko, Maliakkal, Benedict, Nair, Satheesh, Podila, Pradeep S. B., Agbim, Uchenna A., Karri, Saradasri, Khan, Sabrina D., Maluf, Daniel, Eason, James D., Molnar, Miklos Z., Satapathy, Sanjaya K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339195/ https://www.ncbi.nlm.nih.gov/pubmed/32568475 http://dx.doi.org/10.14309/ctg.0000000000000185

Ejemplares similares

Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study
por: Agbim, Uchenna, et al.
Publicado: (2020)

Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients
por: Agbim, Uchenna, et al.
Publicado: (2020)

Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients
por: Yazawa, Masahiko, et al.
Publicado: (2019)

A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation
por: Satapathy, Sanjaya K., et al.
Publicado: (2021)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
por: Satapathy, Sanjaya K., et al.
Publicado: (2017)

Stricturing CMV enteritis in an adult liver transplant recipient
por: Helmick, Ryan A, et al.
Publicado: (2019)

Validation of Prognostic Index for Allograft Outcome in Kidney Transplant Recipients With Transplant Glomerulopathy
por: Talwar, Manish, et al.
Publicado: (2020)

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation
por: Cholankeril, George, et al.
Publicado: (2019)

Role of MRCP in Diagnosing Biliary Anastomotic Strictures After Liver Transplantation: A Single Tertiary Care Center Experience
por: Akbar, Ali, et al.
Publicado: (2018)

Liver Outcome in Renal Transplant Recipients Who Acquired Hepatitis C Infection From an Infected Graft: Study Based on Liver Biopsy Findings
por: Kothadia, Jiten P., et al.
Publicado: (2022)

Artificial Intelligence May Predict Early Sepsis After Liver Transplantation
por: Kamaleswaran, Rishikesan, et al.
Publicado: (2021)

Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
por: Heda, Rajiv, et al.
Publicado: (2021)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

The incidence of cytomegalovirus infection after deceased-donor kidney transplantation from hepatitis-C antibody positive donors to hepatitis-C antibody negative recipients
por: Yazawa, Masahiko, et al.
Publicado: (2020)

Recurrent Cholangiocarcinoma Presenting as Sister Mary Joseph Nodule After Liver Transplantation
por: Muppidi, Vijayadershan, et al.
Publicado: (2020)

Hemorrhagic Cystitis in a Liver Transplant Recipient Secondary to BK Virus
por: Kamal, Faisal, et al.
Publicado: (2017)

Tu1256: METFORMIN USE IS ASSOCIATED WITH LESS FREQUENT SEVERE LIVER INJURY UPON HOSPITAL ADMISSIN WITH COVID-19
por: Kuntzen, Christian, et al.
Publicado: (2022)

Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure
por: Satapathy, Sanjaya K., et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?
por: Singh, Shivaram P., et al.
Publicado: (2021)

Tinospora cordifolia (Guduchi/Giloy)-Induced Liver Injury: A Case Review
por: Nnamani, Ikenna, et al.
Publicado: (2023)

New Biomarker of Preeclampsia in Kidney Transplant Recipients
por: Noda, Ryunosuke, et al.
Publicado: (2022)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli, Surosree, et al.
Publicado: (2019)

Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease
por: Bernstein, David, et al.
Publicado: (2021)

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis
por: Kovalic, Alexander J., et al.
Publicado: (2020)

Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
por: Anirvan, Prajna, et al.
Publicado: (2021)

Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature
por: Abutineh, Iman, et al.
Publicado: (2021)

Rising alcohol-associated liver disease–related mortality rates in the United States from 1999 to 2022
por: Ilyas, Fariha, et al.
Publicado: (2023)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2020)

Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction
por: Sikander, Mohammed, et al.
Publicado: (2020)

Do we really need more evidence to use hepatitis C positive donor kidney more liberally?
por: Joglekar, Kiran, et al.
Publicado: (2017)

Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far
por: Anirvan, Prajna, et al.
Publicado: (2020)

Increasing nonalcoholic fatty liver disease–related mortality rates in the United States from 1999 to 2022
por: Ilyas, Fariha, et al.
Publicado: (2023)

DIETARY MANAGEMENT FOR DYSLIPIDEMIA IN LIVER TRANSPLANT RECIPIENTS
por: PINTO, Andressa S., et al.
Publicado: (2016)

Simultaneous Liver—Kidney Transplantation
por: Puri, Vichin, et al.
Publicado: (2015)

Liver retransplantation for adult recipients
por: Hwang, Shin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gcovr8j5hemhd0j4vfuh1ic0ul